BioCardia, Inc.
Datakwaliteit: 83%
BCDA
Nasdaq
Manufacturing
Chemicals
€ 1,19
▼
€ 0,03
(-2,07%)
Marktkapitalisatie: 12,96 M
Prijs
€ 1,19
Marktkapitalisatie
12,96 M
Dagbereik
€ 1,08 — € 1,21
52-Weeksbereik
€ 1,00 — € 3,20
Volume
81.883
Openen € 1,21
50D / 200D Gem.
€ 1,22
2,95% below
50D / 200D Gem.
€ 1,54
23,25% below
Quick Summary
Belangrijkste Punten
Negative free cash flow of -7,44 M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-2220,78%
Onder sectorgemiddelde (-53,41%)
ROIC-1017,84%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
N/A
Current Ratio1,62
Interest CoverageN/A
Waardering
PE (TTM)
-1,58
Onder sectorgemiddelde (-1,48)
P/B Ratio4,94
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -1,6 | -1,5 |
| P/B | 4,9 | 1,6 |
| ROE % | -2220,8 | -53,4 |
| Net Margin % | — | -41,5 |
| Rev Growth 5Y % | — | 1,8 |
| D/E | — | 0,3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -8,23 M |
| ROE | -2220,78% | ROA | -199,78% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -7,44 M |
| ROIC | -1017,84% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 1,62 |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | 2,06 M | Tangible Book Value | 2,63 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -1,58 | Forward P/E | N/A |
| P/B Ratio | 4,94 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -57,41% | ||
| Market Cap | 12,96 M | Enterprise Value | 7,68 M |
| Per Share | |||
| EPS (Diluted TTM) | N/A | Revenue / Share | N/A |
| FCF / Share | -0,68 | OCF / Share | -0,68 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 90,46% |
| SBC-Adj. FCF | -7,97 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -8,23 M | -7,95 M | -11,57 M | -11,91 M | -12,62 M |
| EPS (Diluted) | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -8,28 M | -8,00 M | -11,64 M | -11,90 M | -12,63 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 4,96 M | 4,39 M | 7,73 M | 8,83 M | 8,56 M |
| SG&A Expenses | 3,32 M | 3,67 M | 4,40 M | 4,42 M | 5,09 M |
| D&A | 24.000,0 | 67.000,0 | 84.000,0 | 82.000,0 | 60.000,0 |
| Interest Expense | — | — | — | — | 0,0 |
| Income Tax | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 3,41 M | 3,72 M | 2,99 M | 9,79 M | 15,72 M |
| Total Liabilities | 2,52 M | 2,89 M | 4,59 M | 4,90 M | 5,34 M |
| Shareholders' Equity | 895.000,0 | 837.000,0 | -1,60 M | 4,89 M | 10,38 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 2,50 M | 2,37 M | 1,10 M | 7,36 M | 12,87 M |
| Current Assets | 2,73 M | 2,62 M | 1,46 M | 7,86 M | 13,48 M |
| Current Liabilities | 2,43 M | 2,32 M | 3,61 M | 3,59 M | 3,71 M |
{"event":"ticker_viewed","properties":{"ticker":"BCDA","listing_kind":"stock","pathname":"/stocks/bcda","exchange":"Nasdaq","country":"US"}}